Medical Microbiology and Immunology

, Volume 198, Issue 2, pp 79–81

Oncomodulation by human cytomegalovirus: evidence becomes stronger

  • Martin Michaelis
  • Hans Wilhelm Doerr
  • Jindrich CinatlJr
Mini Review


  1. 1.
    Michaelis M, Doerr HW, Cinatl J Jr The story of human cytomegalovirus and cancer: increasing evidence and open questions. Neoplasia (in press)Google Scholar
  2. 2.
    Ho M (2008) The history of cytomegalovirus and its diseases. Med Microbiol Immunol (Berl) 197:65–73. doi:10.1007/s00430-007-0066-x CrossRefGoogle Scholar
  3. 3.
    Besold K, Plachter B (2008) Recombinant viruses as tools to study human cytomegalovirus immune modulation. Med Microbiol Immunol (Berl) 197:215–222. doi:10.1007/s00430-008-0083-4 CrossRefGoogle Scholar
  4. 4.
    Böhm V, Podlech J, Thomas D, Deegen P, Pahl-Seibert MF, Lemmermann NA, Grzimek NK, Oehrlein-Karpi SA, Reddehase MJ, Holtappels R (2008) Epitope-specific in vivo protection against cytomegalovirus disease by CD8 T cells in the murine model of preemptive immunotherapy. Med Microbiol Immunol (Berl) 197:135–144. doi:10.1007/s00430-008-0092-3 CrossRefGoogle Scholar
  5. 5.
    Busche A, Angulo A, Kay-Jackson P, Ghazal P, Messerle M (2008) Phenotypes of major immediate-early gene mutants of mouse cytomegalovirus. Med Microbiol Immunol (Berl) 197:233–240. doi:10.1007/s00430-008-0076-3 CrossRefGoogle Scholar
  6. 6.
    Campbell AE, Cavanaugh VJ, Slater JS (2008) The salivary glands as a privileged site of cytomegalovirus immune evasion and persistence. Med Microbiol Immunol (Berl) 197:205–213. doi:10.1007/s00430-008-0077-2 CrossRefGoogle Scholar
  7. 7.
    Doom CM, Hill AB (2008) MHC class I immune evasion in MCMV infection. Med Microbiol Immunol (Berl) 197:191–204. doi:10.1007/s00430-008-0089-y CrossRefGoogle Scholar
  8. 8.
    Erlach KC, Böhm V, Knabe M, Deegen P, Reddehase MJ, Podlech J (2008) Activation of hepatic natural killer cells and control of liver-adapted lymphoma in the murine model of cytomegalovirus infection. Med Microbiol Immunol (Berl) 197:167–178. doi:10.1007/s00430-008-0084-3 CrossRefGoogle Scholar
  9. 9.
    Faßbender M, Herter S, Holtappels R, Schild H (2008) Correlation of dendritic cell maturation and the formation of aggregates of poly-ubiquitinated proteins in the cytosol. Med Microbiol Immunol (Berl) 197:185–189. doi:10.1007/s00430-008-0091-4 CrossRefGoogle Scholar
  10. 10.
    Grey F, Hook L, Nelson J (2008) The functions of herpesvirus-encoded microRNAs. Med Microbiol Immunol (Berl) 197:261–267. doi:10.1007/s00430-007-0070-1 CrossRefGoogle Scholar
  11. 11.
    Holtappels R, Böhm V, Podlech J, Reddehase MJ (2008) CD8 T-cell-based immunotherapy of cytomegalovirus infection: “proof of concept” provided by the murine model. Med Microbiol Immunol (Berl) 197:125–134. doi:10.1007/s00430-008-0093-2 CrossRefGoogle Scholar
  12. 12.
    Lenac T, Arapović J, Traven L, Krmpotić A, Jonjić S (2008) Murine cytomegalovirus regulation of NKG2D ligands. Med Microbiol Immunol (Berl) 197:159–166. doi:10.1007/s00430-008-0080-7 CrossRefGoogle Scholar
  13. 13.
    Martin H, Mandron M, Davrinche C (2008) Interplay between human cytomegalovirus and dendritic cells in T cell activation. Med Microbiol Immunol (Berl) 197:179–184. doi:10.1007/s00430-008-0079-0 CrossRefGoogle Scholar
  14. 14.
    Maul GG, Negorev D (2008) Differences between mouse and human cytomegalovirus interactions with their respective hosts at immediate early times of the replication cycle. Med Microbiol Immunol (Berl) 197:241–249. doi:10.1007/s00430-008-0078-1 CrossRefGoogle Scholar
  15. 15.
    Mersseman V, Böhm V, Holtappels R, Deegen P, Wolfrum U, Plachter B, Reyda S (2008) Refinement of strategies for the development of a human cytomegalovirus dense body vaccine. Med Microbiol Immunol (Berl) 197:97–107. doi:10.1007/s00430-008-0085-2 CrossRefGoogle Scholar
  16. 16.
    Powers C, Früh K (2008) Rhesus CMV: an emerging animal model for human CMV. Med Microbiol Immunol (Berl) 197:109–115. doi:10.1007/s00430-007-0073-y CrossRefGoogle Scholar
  17. 17.
    Sacher T, Jordan S, Mohr CA, Vidy A, Weyn AM, Ruszics Z, Koszinowski UH (2008) Conditional gene expression systems to study herpesvirus biology in vivo. Med Microbiol Immunol (Berl) 197:269–276. doi:10.1007/s00430-008-0086-1 CrossRefGoogle Scholar
  18. 18.
    Seckert CK, Renzaho A, Reddehase MJ, Grzimek NK (2008) Hematopoietic stem cell transplantation with latently infected donors does not transmit virus to immunocompromised recipients in the murine model of cytomegalovirus infection. Med Microbiol Immunol (Berl) 197:251–259. doi:10.1007/s00430-008-0094-1 CrossRefGoogle Scholar
  19. 19.
    Stinski MF, Isomura H (2008) Role of the cytomegalovirus major immediate early enhancer in acute infection and reactivation from latency. Med Microbiol Immunol (Berl) 197:223–231. doi:10.1007/s00430-007-0069-7 CrossRefGoogle Scholar
  20. 20.
    von Müller L, Mertens T (2008) Human cytomegalovirus infection and antiviral immunity in septic patients without canonical immunosuppression. Med Microbiol Immunol (Berl) 197:75–82. doi:10.1007/s00430-008-0087-0 CrossRefGoogle Scholar
  21. 21.
    Waisman A, Croxford AL, Demircik F (2008) New tools to study the role of B cells in cytomegalovirus infections. Med Microbiol Immunol (Berl) 197:145–149. doi:10.1007/s00430-008-0088-z CrossRefGoogle Scholar
  22. 22.
    Waller EC, Day E, Sissons JG, Wills MR (2008) Dynamics of T cell memory in human cytomegalovirus infection. Med Microbiol Immunol (Berl) 197:83–96. doi:10.1007/s00430-008-0082-5 CrossRefGoogle Scholar
  23. 23.
    Wirtz N, Schader SI, Holtappels R, Simon CO, Lemmermann NA, Reddehase MJ, Podlech J (2008) Polyclonal cytomegalovirus-specific antibodies not only prevent virus dissemination from the portal of entry but also inhibit focal virus spread within target tissues. Med Microbiol Immunol (Berl) 197:151–158. doi:10.1007/s00430-008-0095-0 CrossRefGoogle Scholar
  24. 24.
    Yue Y, Wang Z, Abel K, Li J, Strelow L, Mandarino A, Eberhardt MK, Schmidt KA, Diamond DJ, Barry PA (2008) Evaluation of recombinant modified vaccinia Ankara virus-based rhesus cytomegalovirus vaccines in rhesus macaques. Med Microbiol Immunol (Berl) 197:117–123. doi:10.1007/s00430-008-0074-5 CrossRefGoogle Scholar
  25. 25.
    Su BY, Su CY, Yu SF, Chen CJ (2007) Incidental discovery of high systemic lupus erythematosus disease activity associated with cytomegalovirus viral activity. Med Microbiol Immunol (Berl) 196:165–170. doi:10.1007/s00430-007-0040-7 CrossRefGoogle Scholar
  26. 26.
    Cinatl J Jr, Cinatl J, Vogel JU, Rabenau H, Kornhuber B, Doerr HW (1996) Modulatory effects of human cytomegalovirus infection on malignant properties of cancer cells. Intervirology 39:259–269PubMedGoogle Scholar
  27. 27.
    Cobbs CS, Harkins L, Samanta M, Gillespie GY, Bharara S, King PH, Nabors LB, Cobbs CG, Britt WJ (2002) Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res 62:3347–3350PubMedGoogle Scholar
  28. 28.
    Mitchell DA, Xie W, Schmittling R, Learn C, Friedman A, McLendon RE, Sampson JH (2008) Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma. Neuro oncol 10:10–18. doi:10.1215/15228517-2007-035 PubMedCrossRefGoogle Scholar
  29. 29.
    Söderberg-Nauclér C (2008) HCMV microinfections in inflammatory diseases and cancer. J Clin Virol 41:218–223. doi:10.1016/j.jcv.2007.11.009 PubMedCrossRefGoogle Scholar
  30. 30.
    Scheurer ME, Bondy ML, Aldape KD, Albrecht T, El-Zein R (2008) Detection of human cytomegalovirus in different histological types of gliomas. Acta Neuropathol 116:79–86. doi:10.1007/s00401-008-0359-1 PubMedCrossRefGoogle Scholar
  31. 31.
    Lau SK, Chen YY, Chen WG, Diamond DJ, Mamelak AN, Zaia JA, Weiss LM (2005) Lack of association of cytomegalovirus with human brain tumors. Mod Pathol 18:838–843. doi:10.1038/modpathol.3800352 PubMedCrossRefGoogle Scholar
  32. 32.
    Poltermann S, Schlehofer B, Steindorf K, Schnitzler P, Geletneky K, Schlehofer JR (2006) Lack of association of herpesviruses with brain tumors. J Neurovirol 12:90–99. doi:10.1080/13550280600654573 PubMedCrossRefGoogle Scholar
  33. 33.
    Sabatier J, Uro-Coste E, Pommepuy I, Labrousse F, Allart S, Trémoulet M, Delisle MB, Brousset P (2005) Detection of human cytomegalovirus genome and gene products in central nervous system tumours. Br J Cancer 92:747–750. doi:10.1038/sj.bjc.6602339 PubMedCrossRefGoogle Scholar
  34. 34.
    Prins RM, Cloughesy TF, Liau LM (2008) Cytomegalovirus immunity after vaccination with autologous glioblastoma lysate. N Engl J Med 359:539–541. doi:10.1056/NEJMc0804818 PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  • Martin Michaelis
    • 1
  • Hans Wilhelm Doerr
    • 1
  • Jindrich CinatlJr
    • 1
  1. 1.Institut für Medizinische VirologieKlinikum der Johann Wolfgang Goethe-UniversitätFrankfurt am MainGermany

Personalised recommendations